Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 6NIH 5OTHER 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Endocrine 3Genitourinary 2Gastrointestinal 2CNS 2Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 168Lung Neoplasms 148Adenocarcinoma of Lung 37Small Cell Lung Carcinoma 23Adenocarcinoma, Bronchiolo-Alveolar 20Breast Neoplasms 15Mesothelioma, Malignant 13Colorectal Neoplasms 11Colonic Neoplasms 10Prostatic Neoplasms 9Rectal Neoplasms 7Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasm Metastasis 6Melanoma 6Carcinoma, Ovarian Epithelial 6Thymoma 5Pleural Effusion, Malignant 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pain 4Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3

Interventions

vandetanib 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Thyroid Carcinoma, Anaplastic × Thoracic × Clear all
NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡